# Linguistic Disparities in Diabetes Care Quality in California Community Health Centers Before and During the COVID-19 Pandemic

**Authors:** Oscar V. Ramos, Timothy T. Brown, Hector P. Rodriguez

PMC · DOI: 10.1177/21501319241229018 · 2024-02-07

## TL;DR

The study found that patients with limited English proficiency had lower HbA1c control for diabetes compared to non-LEP patients, but care quality remained consistent during the pandemic.

## Contribution

The study reveals persistent disparities in HbA1c control for LEP patients with diabetes, despite stable care quality during the pandemic.

## Key findings

- LEP patients had lower odds of HbA1c control in 2019 and 2020 compared to non-LEP patients.
- There were no significant changes in HbA1c control over time for LEP versus non-LEP patients.
- Blood pressure screening and control were comparable between LEP and non-LEP patients in both years.

## Abstract

Disparities in diabetes care quality may have increased for patients with limited English language proficiency (LEP) compared to non-LEP patients during the COVID-19 pandemic. Changes in diabetes care quality for adult LEP and non-LEP patients of community health centers (CHCs) were examined from 2019 to 2020.

Adults with Type 2 diabetes (n = 15 965) of 88 CHC sites in California and with 1+ visit/year in 2019 and 2020 from OCHIN electronic health record data were included. Multivariable regression models estimated the association of LEP status and changes in diabetes care quality from 2019 to 2020, controlling for patient sociodemographic and clinical characteristics. Interaction terms (LEP × 2020) were used to estimate differential over time changes in (1) blood pressure screening, (2) blood pressure control (<140/90 mm Hg), and (3) hemoglobin A1c control (HbA1c <8%) for LEP versus non-LEP patients.

LEP and non-LEP patients with diabetes had comparable blood pressure screening and control in 2019 and in 2020. LEP patients were less likely than non-LEP patients to have their HbA1c under control in 2019 (OR = 0.85, 95% CI = 0.77, 0.96, P = .006) and 2020 (OR = 0.83, 95% CI = 0.75, 0.92, P = .001). There were no differential changes in HbA1c control over time for LEP and non-LEP patients.

Although LEP patients were less likely than non-LEP patients to have their HbA1c under control, CHCs maintained quality of care equally for LEP and non-LEP patients with diabetes during the early pandemic period.

## Linked entities

- **Diseases:** Type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Diseases:** Diabetes (MESH:D003920), COVID-19 (MESH:D000086382), CHC (MESH:D019698), Type 2 diabetes (MESH:D003924)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10851749/full.md

---
Source: https://tomesphere.com/paper/PMC10851749